MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis |
Stanford University / Feng Pan, PhD |
Young Investigator Grants |
2019 |
California |
Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma |
University of California, San Diego / Alice Yu, MD, PhD |
Innovation Grants |
2011 |
California |
Maternal Comorbidities, Pharmaceutical Use and Childhood Cancers: A Record Linkage Study in Taiwan |
University of California, Los Angeles / Julia Heck, PhD |
Epidemiology Grants |
2017 |
California |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
Factors Affecting Parental Satisfaction, Anxiety and Comprehension of the Informed Consent in Pediatric Oncology Clinical Trials |
University of California, San Diego / Paula Aristizabal, MD |
Psychosocial Grants |
2015 |
California |
Determinants of Testicular Germ Cell Tumor Platinum Sensitivity and Resistance |
University of California, San Diego / Paolo Abada |
Young Investigator Grants |
2012 |
California |
Altered Cerebral Blood Flow after Pediatric Posterior Fossa Brain Tumor Treatment |
Children's Hospital Los Angeles / Mary Baron Nelson, RN/PhD |
Nurse Researcher Grants |
2016 |
California |
Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma
|
Beckman Research Institute of City of Hope / Margarita Gutova, MD |
Reach Grants |
2013 |
California |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children's Hospital Los Angeles / Shahab Asgharzadeh, MD |
Innovation Grants |
2015 |
California |
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture
|
Children's Hospital Los Angeles / Theresa Harned, MD |
Young Investigator Grants |
2006 |
California |